MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/21678421.2025.2471421

Медицинская библиотека · Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025

Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study.

Murray Deirdre, Rooney James, Meldrum Dara, Al-Chalabi Ammar, Bunte Tommy M, Chiwera Theresa, Choudhury Mutahhara, Chio Adriano, Fenton Lauren, Fortune Jennifer, Maidment Lindsay, Manera Umberto, McDermott Christopher J, Meyjes Myrte, Tattersall Rachel, Torrieri Maria Claudia, Van Damme Philip, Vanderlinden Elien, Wood Claire, Van Den Berg Leonard H, Hardiman Orla

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Objective

Progressing respiratory weakness throughout the course of amyotrophic lateral sclerosis (ALS) is clinically associated with distressing symptoms, including dyspnea, orthopnea, and difficulty clearing secretions. Fatigue, poor sleep, and reduced quality of life are also considered to be associated with declining respiratory function. Respiratory measurements guide prescription of interventions, which aim to alleviate symptoms. The relationships between respiratory measurements and patient reported symptoms are currently unclear. Method: The REVEALS study was a longitudinal, observational, multisite study of decline in respiratory function in people with ALS attending six European centers. Respiratory measures (forced and slow vital capacity (F/SVC), sniff nasal inspiratory pressure (SNIP), and peak cough flow) were collected, as were the presence of respiratory symptoms and simple quality of life, fatigue and sleep measures. We used Bayesian's multivariate models to explore the associations of the respiratory measures with outcome variables.

Results

Two hundred and eighty participants completed in-person assessments over a median of 8 (IQR 2.3, 14.1) months, with 974 data collection timepoints. The probability of reporting symptoms including dyspnea, orthopnea, and difficulty clearing secretions increased with decreasing respiratory measurement scores. The probability of reporting moderately low quality of life and moderate fatigue also increased with decreasing test scores, but reported sleep quality was not associated with respiratory scores.

Conclusion

Respiratory weakness in people with ALS was associated with symptoms including dyspnea, orthopnea, and difficulty clearing secretions. The probability of reporting symptoms increased incrementally as respiratory weakness increased, supporting the use of both respiratory measurements and the presence of symptoms in making decisions about clinical interventions.

Для цитирования: Murray Deirdre, Rooney James, Meldrum Dara, Al-Chalabi Ammar, Bunte Tommy M, Chiwera Theresa, Choudhury Mutahhara, Chio Adriano, Fenton Lauren, Fortune Jennifer, Maidment Lindsay, Manera Umberto, McDermott Christopher J, Meyjes Myrte, Tattersall Rachel, Torrieri Maria Claudia, Van Damme Philip, Vanderlinden Elien, Wood Claire, Van Den Berg Leonard H, Hardiman Orla. Respiratory measurements, respiratory symptoms, and quality of life in ALS: results from the REVEALS study.. Amyotrophic lateral sclerosis & frontotemporal degeneration. 2025. DOI: 10.1080/21678421.2025.2471421.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.